statistiche ricercatore

RIVA, CRISTINA

Distribuzione geografica

Continente	#
NA - Nord America	6.822
EU - Europa	4.776
AS - Asia	2.971
SA - Sud America	309
AF - Africa	38
Continente sconosciuto - Info sul continente non disponibili	14
OC - Oceania	4
Totale	14.934

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	6.762
IT - Italia	2.239
SG - Singapore	983
UA - Ucraina	802
CN - Cina	667
VN - Vietnam	440
TR - Turchia	385
SE - Svezia	345
DE - Germania	310
HK - Hong Kong	305
BR - Brasile	271
FR - Francia	253
FI - Finlandia	249
IE - Irlanda	204
GB - Regno Unito	153
RU - Federazione Russa	111
IN - India	62
CA - Canada	32
JP - Giappone	30
NL - Olanda	25
MX - Messico	22
BD - Bangladesh	20
BE - Belgio	20
PL - Polonia	18
EU - Europa	13
ZA - Sudafrica	13
AR - Argentina	12
IQ - Iraq	12
SA - Arabia Saudita	9
PK - Pakistan	8
AT - Austria	6
CH - Svizzera	6
ES - Italia	6
LT - Lituania	6
PH - Filippine	6
UZ - Uzbekistan	6
CO - Colombia	5
ID - Indonesia	5
JO - Giordania	5
KE - Kenya	5
DK - Danimarca	4
EC - Ecuador	4
EG - Egitto	4
PE - Perù	4
TN - Tunisia	4
AE - Emirati Arabi Uniti	3
AU - Australia	3
BO - Bolivia	3
CZ - Repubblica Ceca	3
ET - Etiopia	3
HR - Croazia	3
HU - Ungheria	3
LB - Libano	3
MA - Marocco	3
NP - Nepal	3
OM - Oman	3
PY - Paraguay	3
AM - Armenia	2
GE - Georgia	2
LU - Lussemburgo	2
MY - Malesia	2
NG - Nigeria	2
PA - Panama	2
SN - Senegal	2
UY - Uruguay	2
VE - Venezuela	2
AF - Afghanistan, Repubblica islamica di	1
AL - Albania	1
AZ - Azerbaigian	1
CL - Cile	1
CR - Costa Rica	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
GR - Grecia	1
GY - Guiana	1
HN - Honduras	1
IS - Islanda	1
KR - Corea	1
LV - Lettonia	1
MD - Moldavia	1
MO - Macao, regione amministrativa speciale della Cina	1
MV - Maldive	1
NI - Nicaragua	1
NO - Norvegia	1
NZ - Nuova Zelanda	1
PS - Palestinian Territory	1
QA - Qatar	1
RO - Romania	1
RW - Ruanda	1
SK - Slovacchia (Repubblica Slovacca)	1
SR - Suriname	1
SY - Repubblica araba siriana	1
TH - Thailandia	1
TW - Taiwan	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	14.934

Salva come PNG Salva come JPEG

Città	#
Milan	1.565
Jacksonville	608
Chandler	586
Fairfield	578
San Jose	518
Singapore	517
Ashburn	469
Woodbridge	388
Dearborn	317
Hong Kong	301
Ann Arbor	280
Houston	252
Wilmington	251
Princeton	214
Seattle	203
Dublin	202
Beijing	198
Izmir	190
Nyköping	183
Cambridge	171
Dallas	142
Boardman	127
Rome	117
The Dalles	116
Dong Ket	110
New York	94
Lauterbourg	93
San Mateo	88
Chicago	84
Los Angeles	81
Ho Chi Minh City	75
Como	71
Munich	53
San Diego	50
Hanoi	47
Orem	42
Ogden	41
Helsinki	40
Buffalo	29
Hefei	29
Tokyo	29
Guangzhou	28
Santa Clara	25
Chennai	24
São Paulo	24
London	23
Kunming	20
Nanjing	18
Turku	18
Brussels	17
Manchester	16
Warsaw	16
Denver	15
Jinan	15
Verona	15
Poplar	14
Atlanta	13
Norwalk	13
Amsterdam	12
Brooklyn	12
Da Nang	12
Düsseldorf	12
Nanchang	12
Phoenix	11
Washington	11
Boston	10
Frankfurt am Main	10
Montreal	10
San Francisco	10
Toronto	10
Hangzhou	9
Mexico City	9
New Delhi	9
Ankara	8
Haiphong	8
Johannesburg	8
Pune	8
Rio de Janeiro	8
Casorezzo	7
Catania	7
Changsha	7
Fuzhou	7
Shenyang	7
Stockholm	7
Tianjin	7
Auburn Hills	6
Baghdad	6
Biên Hòa	6
Campinas	6
Nuremberg	6
Redwood City	6
Shanghai	6
Vienna	6
Amman	5
Belo Horizonte	5
Chengdu	5
Council Bluffs	5
Hải Dương	5
Kocaeli	5
Nairobi	5
Totale	10.194

Salva come PNG Salva come JPEG

Nome	#
Loss of function of Ribonuclease T2, an ancient and phylogenetically conserved RNase, plays a crucial role in ovarian tumorigenesis	289
LUTEOMA GRAVIDICO CON ASCITE MASSIVA: DESCRIZIONE DI UN CASO	278
Microsatellite analysis of sporadic and hereditary gynaecological cancer in routine diagnostics	245
Durable recurrence-free survival after pneumonectomy for late lung metastasis from rectal cancer: Case report with genetic and epigenetic analyses	242
Inherited cancer syndromes in 220 Italian ovarian cancer patients	235
Carcinosarcoma of the uterine cervix: Case report and discussion.	230
A cell-autonomous oncosuppressive role of human RNASET2 affecting ECM-mediated oncogenic signaling	228
Somatic Testing on Gynecological Cancers Improve the Identification of Lynch Syndrome	227
Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase.	225
Biochemical and immunohistochemical characterization of human RNASET2 expression	216
Natural history of cervical intraepithelial neoplasia during pregnancy.	215
Two Cases of Carcinosarcomas of the Ovary Involved in Hereditary Cancer Syndromes	212
Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers	207
Oxidative DNA damage induces hypomethylation in a compromised base excision repair colorectal tumourigenesis	206
Endometrial cancer cells can express fibrinogen: Immunohistochemistry and RT-PCR analysis	202
Renal cell carcinoma metastatic to a pituitary FSH/LH adenoma: Case report and review of the literature	189
Primary Extranodal Marginal Cell Lymphoma, MALT Type, of the Endometrium Arising in a Patient With Rheumatoid Arthritis: Report of a Case	189
Identifying factors contributing to reduced breast tumor size: A longitudinal study	181
Primary peritoneal cancer in Lynch syndrome: a clinical-pathologic report of a case and analysis of the literature.	181
Genetic and cytogenetic observations among different types of ovarian tumors are compatible with a progression model underlying ovarian tumorigenesis	178
Immunohistochemical pattern of hMSH2/hMLH1 in familial and sporadic colorectal, gastric, endometrial and ovarian carcinomas with instability in microsatellite sequences	174
Tumor suppression by means of microenvironment-mediated stress response: the role of the human RNASET2 gene	166
"Proximal type" epithelioid sarcoma of the vulva: differential diagnosis with other extrarenal rhabdoid tumors	164
Early Involvement of 6q in Surface Epithelial Ovarian Tumors	164
Targeted gene sequencing of Lynch syndrome–related and sporadic endometrial carcinomas	158
Risk factors for cervical intraepithelial neoplasia recurrence after conization: a 10-year study	157
Physical map of the D6S149-D6S193 region on chromosome 6Q27 and its involement in benign surface epithelial ovarian tumours	156
Human RNASET2 mediates tumor suppression by means of in vivo recruitment of stromal cells	156
CD44 expression in ER and PR negative ductal breast carcinomas	154
Breast carcinomas with neuroendocrine features are neoplasms of low grade malignancy	153
Chromosome 6 abnormalities in ovarian surface epithelial tumors of borderline malignancy suggest a genetic continuum in the progression model of ovarian neoplasms	152
Disorders of the Endocrine System	151
Postoperative complications after pelvic lymphadenectomy for the surgical staging of endometrial cancer.	150
Chromosome 6 abnormalities in borderline ovarian tumours suggest a genetic continuum in the progression model of ovarian neoplasms.	149
Ovarian metastases from colorectal carcinoma. Clinicopathologic profile, immunophenotype, and karyotype analysis	148
6q27 contains candidate genes involved in surface epithelial ovarian tumors. 4th congress of the European Society for Gynecologic and Obstetric Investigation, Madonna di Campiglio, 14-20 marzo, 1999	148
Fetoplacental cytomegalovirus infection. A case report	146
Adenohypophyseal differentiation in ovarian mature cystic teratomas and in ovarian carcinoids	145
Calretinin expression in different molecular subtypes of ER and PR negative breast carcinomas	145
RNASET2 expression in ovarian epithelial tumors and clinico-pathological correlations.	145
The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas.	140
Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma.	139
Tumor antagonizing genes and ovarian cancer: the role of the human RNASET2 gene.	139
Prevalence of HIV-1 primary drug resistance in seroconverters of the ICoNA cohort over the period 1996-2001	138
IDENTIFICAZIONE E TIPIZZAZIONE DEI GENOTIPI HPV AD ALTO RISCHIO NELLE LESIONI PRENEOPLASTICHE DELLA CERVICE UTERINA: CORRELAZIONI CLINICOPATOLOGICHE	137
IMMUNOPHENOTYPIC EVALUATION OF ESTROGEN AND PROGESTERONE RECEPTORS NEGATIVE BREAST CARCINOMAS	137
Diabetic fibrous mastopathy: sonographic-pathologic correlation	137
Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts	136
Intraoperative radioimmunoguided of colo-rectal cancer using monoclonal antibody B72.3 labelled with 125I	136
Microsatellite instability in endometrial cancer. Relation to histological subtypes	133
Prognostic significance of p53, CA19.9 and M3SI expression in ovarian carcinomas	133
Androgen receptors in breast	131
Prognostic significance of karyotype analysis in ovarian carcinomas	131
Clinico-pathological correlations of karyotype analysis in ovarian carcinomas	130
Carcinoma lobulare in situ e invasivo: studio di clonalità con mtDNA	130
RNASET2, a human tumor antagonizing gene supressing tumor growth in vivo but not in vitro	130
Cellular and molecular consequences of peroxisome proliferator-activated receptor-gamma activation in ovarian cancer cells.Neoplasia	128
Clinicopathological features of oral carcinoma: analysis of 240 cases	127
METILAZIONE DE NOVO DI p16, hMLH1 E MGMT NEI CARCINOMI SINCRONI ENDOMETRIALI E OVARICI	124
Instabilità dei microsatelliti e perdita dell’espressione della proteina hMLH1 in carcinomi sincroni endometriali e ovarici	122
Ovarian retiform Sertoli-Leydig cell tumor : clinicopathological study of a case, 22th Int Meeting of the Adriatic Society of Pathology	122
Immunohistochemical expression and methilation status of MGMT in diffuse large B-cells lymphomas	122
The in vivo tumor antagonizing role of human RNASET2 is mediated by host stromal cells recruitment	121
Espressione del recettore degli androgeni nel carcinoma mammario	120
RNASET2 is a non-cell autonomous human tumor suppressor	119
Rnaset2, the first human ribonuclease of the rh/t2/s family, displays a role in tumor suppression	118
Chromosome 6 abnormalities in borderline tumors suggest a genetic continuum in the progression model of ovarian neoplasms	117
LONG-TERM FOLLOW-UP OF IN SITU CARCINOMA OF THE BREAST	115
Histopathology, hormone products, and clinico-pathologic profile of endocrine tumors of the small intestine. A study of 44 cases.	114
Prognostic significance of p53 CA 19-9 and M3SI expression in ovarian carcinomas.	114
“Microsatellite instability and lack of hMLH1 expression in synchronous endometrial and ovarian carcinomas”	113
Pituitary adenomas, a thirty-four-years experience in a –single institution.	112
Correlation between microsatellite instability, clinico-pathological and immunohistochemical features in endometrial carcinomas	110
Prognostic significance of p53, CA19.9 and M3SI expression in ovarian carcinomas	110
Chromosome 6 abnormalities are frequently expressed in Borderline Ovarian Epithelial Tumors suggesting a progression model of ovarian carcinogenesis	110
Instabilità dei microsatelliti e perdita dell'espressione della proteina hMLH1 in carcinomi sincroni endometriali e ovarici	109
Microsatellite instability and lack of hMLH1 expression in syncronous endometrial and ovarian carcinomas	109
Capitolo 9.7: Intestino tenue	109
Non-chromaffin paraganglioma of the cervix uteri. Immunohistochemical and ultrastructural study	107
PLACENTAL MALARIA AS A CAUSE OF INTRPAUTERINE FETAL DEATH IN ASYMPTOMATIC PATIENT. A CASE REPORT	106
ESTROGEN RECEPTOR NEGATIVE INVASIVE BREAST CARCINOMAS FREQUENTLY EXPRESS MYOEPITHELIAL MARKERS	104
Er negative, p53 positive, breast cancers frequently express basal and myoepithelial cell markers	103
Ki67, p53 and pttg-1 expression in invasive pituitary adenomas.	103
Clinico - Pathological profile of Estrogen and Progesteron receptors negatibe breast cancinomas with basal or luminal markers expression	102
The applications of FISH in tumor pathology	102
Microsatellite instability and lack of hMLH1 expression in synchronous endometrial and ovarian carcinomas	101
p53 positive, breast cancers frequently express basal and myoepithelial cell markers	100
IL CARCINOMA MICROINVASIVO DELLA CERVICE	98
Ovarian metastases: clinico-pathological profile, immunophenotype and Karyotype analysis	98
Frequency and chacterization of anterior pituitary component in ovarian mature cystic teratomas.	98
Capitolo 9.6: Stomaco	96
Expression of gastrointestinal markers in pancreatic carcinomas	95
Prognostic significance of karyotype analysis in ovarian carcinomas	94
CLINICO-PATHOLOGICAL PROFILE OF ESTROGEN AND PROGESTERONE NEGATIVE BREAST CARCINOMAS WITH BASAL OR LUMINAL MARKERS EXPRESSION	94
Molecular genetics of syncronous endometrial and ovarian carcinomas	93
Gestione per processi in anatomia patologica. Strumenti di analisi del rischio di errore. Azioni correttive e di miglioramento	93
Correlazioni cisto-isto-colposcopiche in 150 casi consecutivi di patologia cervicale.	93
Ano	91
Aspetti clinico-patologici dei teratomi maturi cistici dell’ovaio e caratterizzazione delle componenti endocrine	90
Capitolo 9.8: Colon-retto	90
Totale	14.329

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	55.238
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	55.238

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	425	0	0	0	0	0	0	0	0	0	65	145	215
2021/2022	1.054	106	126	96	76	46	37	37	69	53	161	83	164
2022/2023	1.460	127	99	105	195	91	299	3	201	219	35	59	27
2023/2024	2.348	394	388	400	413	470	149	9	17	57	16	17	18
2024/2025	1.448	9	21	264	41	49	59	50	81	214	113	137	410
2025/2026	3.240	263	221	121	569	361	222	717	201	392	173	0	0
Totale													15.000